Is H15 (Extract of Boswellia serrata, 'incense') an efficient supplementation to established drug therapy in RA? - Results of a double blinded pilot trial;Ist H15 (Harzextrakt von Boswellia serrata, 'weihrauch') eine sinnvolle erganzung zur etablierten medikamentosen therapie der chronischen polyarthritis? - Ergebnisse einer doppelblinden pilotstudie

Zeitschrift fur Rheumatologie

Volumn 57, Issue 1, 1998, Pages 11-16

  Sander, O ^a   Herborn, G ^a   Rau, R ^a  

^a Evangelisches Fach krankenhaus Ratingen   (Germany)

Author keywords

5 lipoxygenase inhibition; Ayurvedic medicine; H15; Leukotriens; Rheumatoid arthritis

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; AYURVEDIC DRUG; BOSWELLIC ACID; C REACTIVE PROTEIN; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PLANT EXTRACT; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SUPPLEMENTATION; TABLET; TRADITIONAL MEDICINE;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; MEDICINE, AYURVEDIC; MIDDLE AGED; PAIN MEASUREMENT; PLANT EXTRACTS; TREATMENT OUTCOME;

EID: 0031970137     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930050051     Document Type: Article

References (19)

1. Baud L, Perez J, Denis M, Ardaillou R (1987) Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol 138:1190
2. Böker D-K, Winking M (1997) Die Rolle von Boswelliasäuren in der Therapie maligner Gliome, Dt. Ärztebl. 94:A-1197-1199 (Heft 18)
3. Croxtall JD, Choudhury Q, Tokumoto H, Flower RJ (1995) Lipocortin-1 and the control of arachidonic acid release in cell signaling. Biochem Pharm 50:465-474
4. Etzel R (1996) Special extract of BOSWELLIA serrata (H15) in the treatment of rheumatoid arthritis. Phytomedicine 3(1):91-94
5. Goulet JL, Snouwaert JN, Latour AM, Coffman TM, Koller BH (1994) Altered inflammatory responses in leukotriene-defficient mice. Proc Natl Sci USA 91:12852-12856
6. Griffiths RJ, Pettipher ER, Koch K (1995) Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA 92:517-521
7. Henderson WR (1992) The role of leukotrienes in inflammation. Ann Intern Med 121:684-697
8. Heyworth PG, Karnovsky ML, Badwey JA (1989) Protein phosphorylation associated with synergistic stimulation of neutrophils. J Biol Chem 2674:14935
9. Von Keudell C, Letzel H, Koepcke W, et al. (1994) Klinische Wirksamkeit des Weihrauchpräparates H15 bei rheumatoider Arthritis: Ein neues Therapieprinzip durch spezifische 5-Lipoxygenase-Inhibition? Zeitschrift für Rheumatologie 53:V144 (Abstract)
10. Lewis RA, Austen KF, Soberman RJ (1990) Leukotrienes and other products of the 5-lipoxygenase pathway. N Engl J Med 323:645-655
11. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Ann Rev Biochem 55:69-102
12. Ritchie DM, Boyle JA, McInnes JM, et al. (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Quart J Med 37:393-406
13. Rola-Pleszcynski M, Chavaillaz PA, Lemaire J (1986) Stimulation of Interleukin-2 and interferon-gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins Leukotrienes Med 23:207
14. Safayhi H, Sailer E-R, Ammon HPT (1995) Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-β-boswellic acid. Mol Pharmaco 47:1212-1216
15. Saller E-R, Subramanian LR, Rall B, Hoernlein RF, Ammon HPT, Safayhi H (1996) Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol 117:615-618
16. Sharma ML, Bani S, Singh GB (1989) Antiarthritic activity of boswellic acids in bovine serum albumin (BSA)-induced artheitis. Int J Immunopharmacol 11:647-652
17. Smith WL, Meade EA, DeWiit DL (1994) Interactions of PGH synthase isoenzymes-1 and -2 with NSAIDs. Ann NY Acad Sci 744:50-57
18. Weinblatt ME, Kremer JM; Coblyn JS, et al. (1995) Zileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis. J Rheumatol 19:1537-1541
19. Weyand CM, Goronzy J, Fliedner G, Hunstein W (1988) Frühe Basistherapie der rheumatoiden Arthritis: Ergebnisse einer randomisierten Studie. Zeitschrift für Rheumatologie 47:258-259 (Abstract 43)